Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease
Masaaki Konishi, Sunao Kojima, Kazuaki Uchiyama, Naoto Yokota, Eiichi Tokutake, Yutaka Wakasa, Shinya Hiramitsu, Masako Waki, Hideaki Jinnouchi, Hirokazu Kakuda, Takahiro Hayashi, Naoki Kawai, Masahiro Sugawara, Hisao Mori, Kenichi Tsujita, Kunihiko Matsui, Ichiro Hisatome, Yusuke Ohya, Kazuo Kimura, Yoshihiko Saito, Hisao Ogawa
Topics & Concepts
FebuxostatMedicineHyperuricemiaInternal medicineClinical endpointAsymptomaticSubgroup analysisHazard ratioCoronary artery diseaseStroke (engine)CardiologyUric acidRandomized controlled trialConfidence intervalMechanical engineeringEngineeringGout, Hyperuricemia, Uric AcidBiochemical Acid Research StudiesDiet, Metabolism, and Disease